Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 5417 Scientific Research & Development Services |
Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing 339115 Ophthalmic Goods Manufacturing |
Address | 24 Crosby Dr Bedford, MA 01730 |
Ocular Therapeutix | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $10 - $100 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
Ocular Therapeutix P&L | $ Millions |
---|---|
Revenue (Sales) | ![]() |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
AXTOKI Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions | 03/27/2023 |
EXTENLY Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions | 03/27/2023 |
AXPAXTLI Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions | 03/27/2023 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
LEIDOS | Denver, CO | 100 |
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
INC RESEARCH | Raleigh, NC | 27 |
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
SYNEOS HEALTH | Raleigh, NC | 13 |
ILLUMINA | San Diego, CA | 12 |
UT-BATTELLE | Oak Ridge, TN | 11 |
PRA HOLDINGS | Raleigh, NC | 11 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
IROBOT | Bedford, MA | 100 |
LFB USA | Framingham, MA | 16 |
OCULAR THERAPEUTIX | Bedford, MA | 15 |
HOMOLOGY MEDICINE | Bedford, MA | 11 |
AVANIA US GROUP | Marlborough, MA | 10 |
Q-PEAK | Bedford, MA | 10 |
Company | Revenue ($ MM) |
---|---|
![]() |